期刊
EXPERIMENTAL AND THERAPEUTIC MEDICINE
卷 6, 期 1, 页码 172-176出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2013.1078
关键词
adjuvant arthritis; resveratrol; rat; extracellular signal regulated protein kinase1/2
The aim of this study was to investigate the preventive effects of resveratrol (Res) on rats with adjuvant arthritis (AA) and the mechanism(s) of action. An AA model was established by injection of Freund's complete adjuvant (FCA). Vascular endothelial growth factor (VEGF) was visualized in joint specimens using immunohistochemistry. IL-1 beta and TNF-alpha production in synoviocytes was determined by radioimmunoassay (RIA). The mRNA expression of IL-1 beta and TNF-alpha was observed in synoviocytes using the reverse transcription (RT)-PCR method. The synoviocytes of the AA model were stimulated by Res or treated with the protein kinase C (PKC) inhibitor chelerythrine prior to stimulation. The expression of phosphorylated ERK1/2 (p-ERK1/2) was detected by western blotting. Res was able to reduce the elevated levels of IL-1 beta and TNF-alpha, and inhibit the mRNA expression of IL-1 beta and TNF-alpha in the synoviocytes of the AA model rats. VEGF expression in the Res-treated group was significantly lowered. The protein expression levels of p-ERK1/2 were significantly higher in the Res-treated group compared with those of the model group, while p-ERK1/2 was markedly lower in the group pretreated with chelerythrine. Res has a therapeutic effect on AA rats, which may be correlated with its immunoregulatory actions, and may activate p-ERK1/2 in synoviocytes via PKC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据